Zamira Life Sciences has raised funds
Zamira Life Sciences has completed a fundraising to accelerate growth.
Zamira is focused on providing innovative, research-based solutions to improve the health, well-being and productivity of food-producing animals. Products and services prevent and treat key animal diseases to ensure safe and sustainable food production. They are favorably positioned as a premium brand with localized understanding and expertise – a trusted and strong Australian brand identity amongst its international competitors.
Oaklins’ team in Australia acted as corporate advisor and lead manager to the raise.
Talk to the deal team
Related deals
Triscan has joined APA and Riverarch to accelerate growth in the European aftermarket
Triscan AS, a leading provider of OE-quality automotive spare parts for the professional aftermarket in Europe, has been acquired by APA Industries, LLC, a portfolio company of Riverarch Equity Partners.
Learn moreEuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Learn moreTEAM Safety Services Limited has been acquired by Vadella Group
TEAM Safety Services Limited, a leading UK-based health, safety and fire safety consultancy, has been acquired by Vadella Group, a specialist provider of inspection-led compliance services for the built environment.
Learn more